Applications of Positron Emission Tomography (PET) in Tumor Management

  • Randall A. Hawkins
  • Michael E. Phelps
Part of the Medical Radiology book series (MEDRAD)

Abstract

Positron emission tomography (PET), also referred to as positron computed tomography (PCT) provides cross sectional images of the body as do other axial tomographic techniques including x-ray computed tomography (x-ray CT) and nuclear magnetic resonance imaging (NMR) (also referred to as MRI, magnetic resonance imaging). Unlike x-ray CT images, which are anatomic representations of the attenuation characteristics of tissue, PET images reflect physiologic processes such as metabolism and blood flow (Phelps et al. 1982 and Phelps and Mazziotta 1985). While most of the initial clinical experience with MRI has also resulted in primarily anatomic representations of pathology, the full potential of this technique, like PET, remains to be explored. Nevertheless, studies to date have already demonstrated the potential of PET to provide quantitative and pictorial physiologic descriptions of neoplasms that complement anatomic images obtained with other modalities. This information is particularly relevant to radiation therapy where varying levels of tissue oxygenation and blood flow can have significant therapeutic implications and to oncology in general where metabolic parameters generated by PET studies can be significant both diagnostically and therapeutically.

Keywords

Permeability Ischemia Half Life Neurol Methionine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen N (1972) Oxidative metabolism of brain tumors. Progr Exp Tumor Res 17: 192–209PubMedGoogle Scholar
  2. Beaney RP, Lammertsma AA, Jones T, McKenzie CG, Halnan KE (1984) Positron emission tomography for in vivo measurement of regional blood flow, oxygen utilization, and blood volume in patients with breast carcinoma. The Lancet, Jan. 21, 131–134Google Scholar
  3. Bergstrom M, Collins VP, Ehrin E, Ericson K, Eriksson L, Greitz T, Halldin C, von Holst H, Langstrom B, Lilja A, Lundquist H, Nagren K (1983) Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr 7: 1062–1066PubMedCrossRefGoogle Scholar
  4. Blasberg RG, Fenstermacher JD, Patlak CS (1983) Transport of a-aminobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow and Metabol 3: 8–32CrossRefGoogle Scholar
  5. Di Chiro G, Brooks RA, Patronas NJ, Bairamian D, Kornblith PL, Smith BH, Mansi L, Barker J (1984) Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 15 (Suppl): S138–146PubMedCrossRefGoogle Scholar
  6. Frackowiak SJ, Lenzi GL, Jones T, Heather JD (1980) Quantificative measurement of regional cerebral blood flow and oxygen metabolism in man using ’ 50 and positron emission tomography: Theory, procedure and normal values. J Comput Tomogr 4: 727–736Google Scholar
  7. Hawkins RA, Phelps ME, Huang S-C, Wapenski JA, Grimm PD, Parker RG, Juillard G, Greenberg P (1984) A kinetic evaluation of blood brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography. J Cereb Blood Flow Metab 4: 507–515PubMedCrossRefGoogle Scholar
  8. Hawkins RA, Phelps ME, Huang S-C, Wapenski JA, Silberman AW (1985) Quantitative estimations of blood brain barrier (BBB) permeability with Ga-68 EDTA and glucose metabolism with F-18 FDG in human brain tumors with PET. J Cereb Blood Flow Metab 5 (Suppl 1), S 583–584Google Scholar
  9. Hoffman EJ, Ricci AR, van der Stec LMAM, Phelps ME (1983) ECAT III — Basic design considerations IEEE Trans Nucl Sci NS-30:729–733Google Scholar
  10. Huang S-C, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238: E69 - E82PubMedGoogle Scholar
  11. Huang S-C, Carson RE, Hoffman EJ, Carson J, MacDonald N, Barrio JR, Phelps ME (1983) Quantitative measurement of local cerebral blood flow in humans by positron computed tomography and 150-water. J Cereb Blood Flow Metabol 3: 141–153CrossRefGoogle Scholar
  12. Ito M, Lammertsma AA, Wise RJS, Bernardi S, Frackowiak RSJ, Heather JD, McKenzie CG, Thomas DGT, Jones T (1982) Measurement of regional cerebral blood flow and oxygen utilization in patients with cerebral tumors using 150 and positron emission tomography: Analytical techniques and preliminary results. Neuroradiology 23: 63–74Google Scholar
  13. Kirsch WM, Tucker WS, Tabuchi K, Fink LM, Van Buskirk JJ, Low M (1977) The metabolism of the glioblastoma: Pathological correlates. Clin Neurosurg 25: 310–325Google Scholar
  14. Lammerstma AA, Brooks DJ, Frackowiak RSJ, Heather JD, Jones T (1984) A method to quantitate fractional extraction of rubidium-82 across the blood brain barrier using positron emission tomography. J Cereb Blood Flow Metab 4: 523–534, 1984Google Scholar
  15. Patronas NJ, Di Chiro G, Brooks RA, De La Paz RL, Kornblith PL, Smith BH, Rizzoli V, Kessler RM, Manning RG, Channing M, Wolf AP, O’Connor CM (1982) Work in Progress: [18F]Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiol 144: 885–889Google Scholar
  16. Patronas NJ, Brooks RA, De La Paz RL, Smith BH, Kornblith PL, Di Chiro G (1983) Glycolytic rate ( PET) and contrast enhancement CT in human cerebral glomas. AJNR 4: 533–535Google Scholar
  17. Phelps ME, Hoffman EJ, Huang S-C (1979a) Single-slice versus multiple-slicepositron tomography. J Nucl Med 20: 800–802Google Scholar
  18. Phelps ME, Huang S-C, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979b) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 6: 371–388Google Scholar
  19. Phelps ME, Mazziotta JC, Huang S-C (1982) Study of cerebral function with positron computed tomography. J Cereb Blood Flow Metab 2: 113–162PubMedCrossRefGoogle Scholar
  20. Phelps ME, Schelbert HR, Mazziotta JC (1983) Positron computed tomography for studies of myocardial and cerebral function. Ann Int. Med 98: 339–359Google Scholar
  21. Phelps ME, Barrio JR, Huang S-C, Keen RE, Chugani H, Mazziotta JC (1984) Criterial for the tracer kinetic measurement of cerebral protein synthesis in humans with positron emission tomography. Ann Neurol 15 (Suppl): S192 - S202PubMedCrossRefGoogle Scholar
  22. Phelps ME, Mazziotta JC (1985) Positron emission tomography: human brain function and biochemistry. Science 228: 799–809PubMedCrossRefGoogle Scholar
  23. Rapoport SI (1976) Blood brain barrier in physiology and medicine. Raven Press, New YorkGoogle Scholar
  24. Reivich M, Kuhl DE, Wolf A, Greenberg J, Phelps ME, Ido T, Casella V, Fowler J, Hoffman E, Alavi, Som P, Sokoloff L (1979) The (18F)-fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44: 127–137Google Scholar
  25. Rhodes CG, Wise RJS, Gibbs JM, Frackowiak RSJ, Hatazawa J, Palmer AJ, Thomas DGT, Jones T (1983) In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 14: 614–626PubMedCrossRefGoogle Scholar
  26. Rottenberg DA, Ginos JZ, Kearfott KJ, Junck L, Bigner DD (1984) In vivo measurement of regional brain tissue pH using positron emission tomography. Ann Neurol 15 (Suppl): S98 - S102PubMedCrossRefGoogle Scholar
  27. Siesjo BK (1978) Brain energy metabolism. John Wiley and Sons, Chichester, New York, Brisbane and TorontoGoogle Scholar
  28. Smith CB, Davidsen L, Deibler G, Patlak C, Pettigrew K, Sokoloff L (1980) A method for the determination of local rates of protein synthesis in brain. Trans Am Soc Neurochem 11: 94Google Scholar
  29. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The (14C)-deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897–916Google Scholar
  30. Ter-Pogossian MM, Mullani NA, Ficke DC, Markham J, Snyder DL (1981) Photon time-of-flight assisted positron emission tomography. J Comput Assist Tomogr 5: 227–229PubMedCrossRefGoogle Scholar
  31. Timperley RW (1980) Glycolysis in neuroectodermal tumors. In: Thomas BT, Graham DI (eds) Brain tumors, scientific basis, clinical investigation and current therapy. Butterworth and Company, London, pp 145–167Google Scholar
  32. Warburg O (1930) The metabolism of tumors. Arnold Constable, London, pp 75–327Google Scholar
  33. Weber G (1977) Enzymology of cancer cells. N Engl J Med: 486–493, 541–551CrossRefGoogle Scholar
  34. Welch MF, Tewson TJ (1979) Radiopharmaceuticals for neurological studies. In: Sorenson JA (ed) Radiopharmaceuticals II. Soc Nucl Med New York, pp 201–219CrossRefGoogle Scholar
  35. Withers HR, Peters LJ (1980) Biological aspects of radiation therapy. In: Fletcher GH (ed) Textbook of Radiotherapy, 3rd ed. Lea & Febiger, Philadelphia, pp 103179Google Scholar
  36. Wolf A (1981) Special characteristics and potential for radiopharmaceuticals for positron emission tomography. Semin Nucl Med 11: 2–12PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • Randall A. Hawkins
    • 1
  • Michael E. Phelps
    • 1
  1. 1.University of CaliforniaLos AngelesUSA

Personalised recommendations